Christopher P. Stewart - 19 Nov 2021 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Chief Financial Officer
Signature: /s/ Christopher P. Stewart
Issuer symbol: BNGO
Transactions as of: 19 Nov 2021
Net transactions value: +$12,600
Form type: 4
Filing time: 23 Nov 2021, 05:00:24 UTC
Previous filing: 27 May 2021
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Options Exercise	$12,600	+22,500	+68%	$0.5600	55,500	19 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Options Exercise	$0	-22,500	-11%	$0.000000	177,500	19 Nov 2021	Common Stock	22,500	$0.5600	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.